Current print subscribers can create a free account by clicking here
Otherwise, follow the link below to join.
To Our Valued Readers –
Visitors to our website will be limited to five stories per month unless they opt to subscribe. The five stories do not include our exclusive content written by our journalists.
For $6.99, less than 20 cents a day, digital subscribers will receive unlimited access to YourValley.net, including exclusive content from our newsroom and access to our Daily Independent e-edition.
Our commitment to balanced, fair reporting and local coverage provides insight and perspective not found anywhere else.
Your financial commitment will help to preserve the kind of honest journalism produced by our reporters and editors. We trust you agree that independent journalism is an essential component of our democracy. Please click here to subscribe.
Need to set up your free e-Newspaper all-access account? click here.
Non-subscribers
Click here to see your options for becoming a subscriber.
Register to comment
Click here create a free account for posting comments.
Note that free accounts do not include access to premium content on this site.
I am anchor
Local lab offers colon cancer blood test
Posted
Colorectal cancer is the second leading cause of cancer deaths in women and men combined.
Despite being one of the most preventable cancers, colorectal cancer claims 50,000 deaths and 135,000 newly diagnosed cases annually.
If detected early enough, it can be treated or cured.
Sonora Quest Laboratories now provides a new colorectal cancer screening blood test, an alternative to a colonoscopy, available directly to consumers without a physician’s order.
The self-ordered lab test product is available online and at all of Sonora Quest’s 70-plus patient service centers in Arizona. The local office is at 13620 N. Saguaro Blvd., suite 150.
The blood test is available for $170. Medicare does not cover the cost. Other insurance plans vary.
Sonora Quest teamed up with Beacon Biomedical Inc., a Phoenix-based diagnostic laboratory focused on commercializing early detection cancer tests. The manufacturer claims the test is 94 percent accurate at detecting the likely presence or absence of colorectal cancer, even at its earliest stage.
As a blood test, it has the potential to remove many of the barriers to screening due to the test’s simplicity and easy of adoption, and can be collected at the same time as other blood tests with no special preparation needed.